Breaking News Bar

Business News and Information

Novavax charges ahead with $200M in fresh capital — and a familiar face on its board

The developments follow the company’s preparations to sell up to $250 million in common stock less than a month ago.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear